The Alpha-1 Foundation has created a letter template for Alpha-1 patients to qualify for early immunization against COVID-19.
The Centers for Disease Control and Prevention (CDC), the National Academy of Medicine, and state health authorities have worked hard to develop prioritization strategies for SARS-CoV-2 vaccine administration based on exposure and risk. All plans for vaccine distribution have included individuals with medical conditions that increase the risk of severe disease due to COVID-19 within the groups that will be offered the vaccine soon after FDA approval.
There are numerous rare diseases that were not specifically included in these priority lists. After communication with the CDC, it was suggested that individuals with rare conditions that likely put them at increased risk should be considered within those high-risk groups, even though those conditions are not specifically mentioned by name in the prioritization.
